Neuroscience · Body

The Neurotransmitter Cheat Sheet: Five Systems And What They Actually Do

Dopamine, serotonin, norepinephrine, acetylcholine, GABA: the five neurotransmitter systems behind most of your cognition and behavior, what each one actually does, and why they don't work alone.

https://taskcoach.ai/blog/neurotransmitter-cheat-sheet-five-systems/

Five systems do most of the work

Five-system brain map showing the distinct and overlapping roles of dopamine, serotonin, norepinephrine, acetylcholine, and GABA.

Your brain runs on more than a hundred different neurotransmitters, but for everyday cognition and behavior, five of them do almost all of the heavy lifting:

  1. Dopamine, for motivation, reward prediction, and drive
  2. Serotonin, for mood stability, social hierarchy, and satiety
  3. Norepinephrine, for arousal, attention, and threat detection
  4. Acetylcholine, for learning, working memory, and focus
  5. GABA, for inhibition, calm, and sleep onset

Understanding what each one actually does, instead of the pop-science cartoon version, is the foundation for making sense of mood, focus, anxiety, addiction, and most of the things (food, exercise, supplements, drugs) that people use to try to influence them.

Dopamine tracks prediction error, not pleasure

The most common myth in pop neuroscience is that dopamine is the "pleasure chemical."

It isn't.

In 1997, neuroscientist Wolfram Schultz and colleagues at Cambridge showed, in work that's been replicated thousands of times since, that dopamine actually encodes reward prediction error: the gap between what you expected to get and what you actually got.

Get exactly the reward you expected, and there's no dopamine signal. Get more than expected, and dopamine spikes. Get less, and it dips below baseline.

That's why novelty reliably triggers a dopamine hit, and why familiar pleasures fade over time. Your brain isn't tracking pleasure directly. It's tracking surprise relative to what it predicted.

The behavioral upshot: dopamine drives wanting a reward, not liking it once you have it. Researcher Kent Berridge's lab at Michigan pinned this down cleanly in the 1990s: animals with their dopamine reward systems chemically depleted still "liked" sweet food just as much, showing the same facial reactions as before, but stopped working to get it.

That's part of why depression and anhedonia can coexist with an intact ability to enjoy things once they actually happen. The wanting system goes offline while the liking system stays intact.

Serotonin governs stability, status, and satiety

Serotonin is famous because of SSRIs like Prozac and Zoloft. But here's the puzzle: an SSRI raises your synaptic serotonin levels within hours, yet the clinical benefit doesn't show up for two to six weeks. Why the delay?

The best current explanation is that SSRIs don't work by simply "raising serotonin." They work by triggering neuroplasticity, specifically changes in BDNF expression and how neurons remodel their connections, and that slower process is what actually shifts mood regulation at the circuit level. Serotonin is the trigger. Plasticity is the mechanism.

Functionally, serotonin is behind mood stability (not happiness exactly, but resistance to mood swings), how you perceive your position in a social hierarchy (this shows up clearly in primate studies), and satiety, both the literal kind involving gut serotonin signaling and the behavioral "I've had enough" signal.

About 90% of your body's serotonin actually lives in your gut, and most of it stays local rather than crossing into your brain directly. But your gut and brain talk to each other through the vagus nerve, so gut serotonin still ends up influencing mood indirectly.

Norepinephrine drives arousal and attention

Norepinephrine, also called noradrenaline, is your brain's arousal and attention signal. It's produced mainly in the locus coeruleus, a small brainstem structure that projects out to almost your entire cortex.

It handles sustained attention (the "stay alert and oriented" signal), threat detection (the fight-or-flight piece), and memory consolidation, which is part of why emotionally charged moments tend to stick in memory so vividly.

ADHD stimulant medications like Ritalin and Adderall raise both dopamine and norepinephrine, and the norepinephrine part is why stimulants sharpen focus even in people who don't have ADHD. They're acting directly on the attention system, not just the motivation system.

Too much norepinephrine from chronic stress feeds anxiety, hypervigilance, and disrupted sleep. This follows the classic Yerkes-Dodson pattern: too little norepinephrine and you're inattentive, the right amount and you're focused and engaged, too much and you tip into anxiety and impaired performance.

Acetylcholine handles learning and working memory

Acetylcholine carries the focus and learning signal. Anticholinergic side effects (the Benadryl brain fog) make the role obvious.

Acetylcholine is your focus and learning neurotransmitter. It's central to working memory (the ability to hold something in mind), sustained attention (related to but distinct from norepinephrine-driven arousal), and memory consolidation, especially during REM sleep.

The clearest evidence for what acetylcholine does comes from what happens when you block it. Anticholinergic drugs, antihistamines like Benadryl, some sleep aids, some bladder medications, cause brain fog and memory problems as a direct side effect of suppressing acetylcholine.

Acetylcholine decline is also a major mechanism behind Alzheimer's pathology, which is why drugs like donepezil work by trying to preserve what acetylcholine is left.

If you're looking at supplements, alpha-GPC and CDP-choline are acetylcholine precursors, while lion's mane works differently, stimulating nerve growth factor, which supports cholinergic neurons indirectly over months.

GABA is the brake

GABA, short for gamma-aminobutyric acid, is your brain's main inhibitory neurotransmitter. Where the first four systems mostly excite or modulate, GABA calms things down.

It handles anxiety reduction (by dampening an overactive amygdala), sleep onset (GABA-A receptor activation is behind most sleep medications), and muscle relaxation, both physical and mental.

Every drug that acts on GABA-A receptors shares a similar clinical fingerprint: benzodiazepines like Xanax and Valium, alcohol (yes, primarily a GABA-A drug), Z-drugs like Ambien, L-theanine (a gentler partial agonist with no dependence risk), and magnesium and taurine, which act as milder modulators.

Chronic use of GABA-boosting substances like alcohol or benzodiazepines downregulates your GABA-A receptors over time, which is exactly why withdrawal produces the opposite of calm: anxiety, insomnia, and in severe cases, seizures.

What this means in practice

Three things follow from all this:

Most symptoms involve more than one system. "I can't focus" could mean low dopamine (motivation), low norepinephrine (arousal), low acetylcholine (working memory), or too much GABA (over-inhibition). The right fix depends entirely on which one is actually off.

Single-target fixes are rare. Most food, exercise, and lifestyle changes touch several systems at once. A run raises BDNF, serotonin, dopamine, and norepinephrine all together. Fixing your sleep touches all five systems.

Medications come with predictable trade-offs. SSRIs blunt dopamine for some people (hence sexual side effects). Stimulants disrupt sleep through leftover norepinephrine. Benzodiazepines impair learning through acute GABA-A activation in the hippocampus.

How TaskCoach.AI uses this

The supplement stack guides and the mood and focus tracking in Analytics are both built around this multi-system view. The AI coach doesn't hand out "your dopamine is low, take L-tyrosine" pop-neuroscience advice. It asks about the actual pattern, sleep, mood, energy, attention, and surfaces interventions that match the full signature, not just one neurotransmitter.

Mood tracking specifically asks about two separate axes: valence (positive to negative, closer to serotonin) and arousal (calm to tense, closer to norepinephrine and GABA balance), rather than a single "how do you feel" rating. That two-axis data is what actually distinguishes "depressed and exhausted" from "anxious and wired," two patterns that need opposite interventions.

The bottom line

Five systems. Five different jobs. Constant overlap between them.

Dopamine wants. Serotonin stabilizes. Norepinephrine arouses. Acetylcholine learns. GABA dampens.

Most cognitive and emotional patterns involve several of these at once, so single-system explanations like "you just have low dopamine" are usually wrong, or at least incomplete. The interventions that actually work tend to nudge several systems gently in the right direction over weeks, not spike one system and crash.

Frequently asked questions

What are the five main neurotransmitter systems?

Dopamine (motivation, reward prediction, drive), serotonin (mood stability, social hierarchy, satiety), norepinephrine (arousal, attention, threat detection), acetylcholine (learning, working memory, focus), and GABA (inhibition, calm, sleep onset). They interact constantly, so explanations that point to just one system usually miss what's really going on.

Is dopamine really the 'pleasure chemical'?

No. Landmark 1997 research out of Cambridge, replicated thousands of times since, showed dopamine encodes reward prediction error: the gap between what you expected and what you got. Pleasure itself is tied more closely to opioid signaling. Dopamine is about the chase, not the payoff.

How do SSRIs actually work?

Not by instantly 'boosting mood.' They raise synaptic serotonin within hours, but the clinical benefit takes two to six weeks because the real mechanism is downstream: neuroplastic changes like shifts in BDNF and how neurons remodel their connections, not the immediate serotonin level itself.

Why do alcohol, benzodiazepines, and L-theanine all feel calming?

All three act on GABA-A receptors, your brain's main inhibitory system. That shared mechanism is why they produce similar effects (calm, sedation) and similar tolerance and withdrawal patterns with regular use.